Britain asks regulator to assess Pfizer vaccine for suitability
LONDON (Reuters) - Britain has formally asked its medical regulator, the MHRA, to assess the COVID-19 vaccine being produced by Pfizer Inc and its German partner BioNTech , health minister Matt Hancock said on Friday. The announcement follows news that Pfizer said it would apply to U.S. health regulators for emergency use authorization (EUA) of its vaccine, the first such application in a major step toward providing protection against the new coronavirus.
LONDON (Reuters) - Britain has formally asked its medical regulator, the MHRA, to assess the COVID-19 vaccine being produced by Pfizer Inc
The announcement follows news that Pfizer said it would apply to U.S. health regulators for emergency use authorization (EUA) of its vaccine, the first such application in a major step toward providing protection against the new coronavirus .
"Here in the UK, the first step for authorising a vaccine is for the government formally to ask the independent regulator ..., the MHRA, to assess its suitability," Hancock told reporters.
"I can confirm that the government has formally asked the MHRA to assess the Pfizer BioNTech vaccine for its suitability for authorisation."
Hancock said Pfizer BioNTech has already starting supplying data to the medical regulator and will submit more in the coming days.
"This is another important step forward in tackling this pandemic," he said. "If a vaccine is approved it will, of course, be available across the UK from our NHS (National Health Service), free at the point of delivery, according to need, not ability to pay."
Health officials stressed that the MHRA was independent and highly regarded. Jonathan Van Tam, England's deputy chief medical officer, said the MHRA would work "at the speed of science".
(Reporting by Kate Holton and Elizabeth Piper; editing by Stephen Addison)
This story has not been edited by Firstpost staff and is generated by auto-feed.
By Chuck Mikolajczak NEW YORK (Reuters) - A gauge of global stocks hit a record and oil prices jumped on Monday as the newest positive data for a potential COVID-19 vaccine and signs of economic recovery in Asia boosted sentiment. U.S. stocks advanced, with the Dow Industrials setting a record as it neared the 30,000 mark for the first time, after pharma company Moderna said its prospective vaccine was 94.5% effective in preventing the illness, which has crushed economies across the globe
By Anirban Sen and Joshua Franklin (Reuters) - Airbnb Inc's initial public offering (IPO) registration showed on Monday that the home rental startup turned a profit in the third quarter despite the COVID-19 pandemic, as it gears up for one of the most anticipated stock market debuts in recent years. The filing, published ahead of Airbnb's anticipated stock market debut in December, showed a dramatic recovery in its fortunes, after the coronavirus outbreak dragged down its core home rental business during the first half of the year. The slump forced it to lay off 25% of its workforce in May, suspend marketing activities for the year and seek $2 billion (£1.5 billion) emergency funding from investors, including Silver Lake and Sixth Street Partners, at a valuation of $18 billion
By David Lawder WASHINGTON (Reuters) - U.S. President-elect Joe Biden said on Monday the United States needed to negotiate with allies to set global trading rules to counter China's growing influence but declined to say whether he would join a new China-backed Asian trade pact signed on Sunday.